Skip to content
10-Q/A

Quarterly Report

Apotheca Biosciences, Inc.

0001079974-19-000337

← back to feed
Filed
Jun 20, 2019 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Jun 19, 2019 118.66M sh
Operating Cash Flow Q1 2020 · Apr 30, 2019 −$105.67K
Operating Cash Flow Q1 2020 · Apr 30, 2018 $296
Cash And Equivalents Q1 2020 · Apr 30, 2019 $250.48K
Cash And Equivalents Q1 2020 · Jan 31, 2019 $2.94K
Stockholders Equity Q1 2020 · Apr 30, 2019 −$709.68K
Stockholders Equity Q1 2020 · Jan 31, 2019 −$816.55K
Stockholders Equity Q1 2020 · Feb 25, 2018 $1
Current Liabilities Q1 2020 · Apr 30, 2019 $1.18M
Current Liabilities Q1 2020 · Jan 31, 2019 $931.88K
Total Liabilities Q1 2020 · Apr 30, 2019 $1.21M
Total Liabilities Q1 2020 · Jan 31, 2019 $931.88K
Current Assets Q1 2020 · Apr 30, 2019 $360.77K
Current Assets Q1 2020 · Jan 31, 2019 $108.88K
Total Assets Q1 2020 · Apr 30, 2019 $503.05K
Total Assets Q1 2020 · Jan 31, 2019 $115.33K
Sga Expense Q1 2020 · Apr 30, 2019 $63.54K
Sga Expense Q1 2020 · Apr 30, 2018 $8.24K
Net Income Q1 2020 · Apr 30, 2019 −$2.67K
Net Income Q1 2020 · Apr 30, 2018 −$38.24K
Operating Income Q1 2020 · Apr 30, 2019 −$299.08K
Operating Income Q1 2020 · Apr 30, 2018 −$38.24K
Revenue Q1 2020 · Apr 30, 2019 $0
Revenue Q1 2020 · Apr 30, 2018 $0